Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126185101 | 12618510 | 1 | I | 20160722 | 0 | 20160802 | 20160802 | DIR | 78.00 | YR | F | N | 0.00000 | 20160801 | Y | PH | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126185101 | 12618510 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | D | D | TCNV | 20180430 | 0 | 10 | MG | Q12H | ||||
126185101 | 12618510 | 3 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
126185101 | 12618510 | 5 | C | CEPHALEXIN. | CEPHALEXIN | 1 | 0 | ||||||||||||
126185101 | 12618510 | 7 | C | BUPROPION. | BUPROPION | 1 | 0 | ||||||||||||
126185101 | 12618510 | 9 | C | QUAIFENESSIN-CODEINE | 2 | 0 | |||||||||||||
126185101 | 12618510 | 11 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
126185101 | 12618510 | 13 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | 0 | ||||||||||||
126185101 | 12618510 | 15 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
126185101 | 12618510 | 17 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 19 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 21 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
126185101 | 12618510 | 23 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 25 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | 0 | ||||||||||||
126185101 | 12618510 | 27 | C | SEPTRA DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 | ||||||||||||
126185101 | 12618510 | 29 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
126185101 | 12618510 | 31 | C | PEPCID | FAMOTIDINE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 32 | C | PROCARDIA XL | NIFEDIPINE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 33 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 35 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
126185101 | 12618510 | 37 | C | APAP-CODEINE | 2 | 0 | |||||||||||||
126185101 | 12618510 | 39 | C | NYSTATIN. | NYSTATIN | 1 | 0 | ||||||||||||
126185101 | 12618510 | 41 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
126185101 | 12618510 | 43 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
126185101 | 12618510 | 45 | C | HIPREX | METHENAMINE HIPPURATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126185101 | 12618510 | 1 | Multiple sclerosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126185101 | 12618510 | Laboratory test abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
Event ID | CASEID | RPSR COD |
---|---|---|
126185101 | 12618510 | HP |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126185101 | 12618510 | 1 | 201006 | 0 |